NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease (vol 4, e006364, 2014). Lawlor, B., Kennelly, S., O'Dwyer, S., Cregg, F., Walsh, C., Coen, R., Kenny, R. A., Howard, R., Murphy, C., Kelly, J., & others BMJ OPEN, BMJ PUBLISHING GROUP BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H~…, 2015.
bibtex   
@article{lawlor2015nilvad,
  title={NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease (vol 4, e006364, 2014)},
  author={Lawlor, Brian and Kennelly, Sean and O'Dwyer, Sarah and Cregg, Fiona and Walsh, Cathal and Coen, Robert and Kenny, Rose Anne and Howard, Robert and Murphy, Caroline and Kelly, Joanna and others},
  journal={BMJ OPEN},
  volume={5},
  number={9},
  year={2015},
  publisher={BMJ PUBLISHING GROUP BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H~…}
}

Downloads: 0